A Multicenter Randomized Double-blind Active-controlled Parallel Group Phase III Trial to Evaluate the Equivalence in Efficacy and Safety of HD203 and Enbrel in Combination With Methotrexate in Patients With Rheumatoid Arthritis.

Trial Profile

A Multicenter Randomized Double-blind Active-controlled Parallel Group Phase III Trial to Evaluate the Equivalence in Efficacy and Safety of HD203 and Enbrel in Combination With Methotrexate in Patients With Rheumatoid Arthritis.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Feb 2016

At a glance

  • Drugs Etanercept (Primary) ; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Registrational; Therapeutic Use
  • Acronyms HERA
  • Sponsors Hanwha Chemical
  • Most Recent Events

    • 23 Feb 2016 Results published in the Annals of the Rheumatic Diseases
    • 14 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 14 Jun 2011 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top